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1. Introduction 
Biomaterials are based on a broad range of materials, such as organic polymers, metals and 
ceramics including both sintered and chemically bonded ceramics (silicates, aluminates, 
sulphates and phophates). The biomaterials can be made prior to use in the body in a 
conventional preparation of the material. The need for in situ in vivo formed implant 
materials makes the chemically bonded ceramics especially potential as biomaterials. These 
ceramics include room/body temperature formed biomaterials with excellent 
biocompatibility. Ca-aluminate as a biomaterial has been evaluated for over two decades 
with regard to general physical, mechanical and biocompatible properties. The Ca-
aluminate based materials exhibit due to their unique curing/hardening characteristics and 
related microstructure a great potential within the biomaterial field. The presentation in this 
chapter aims at giving an overview of the use of Ca-aluminate (CA) as a biomaterial within 
odontology, orthopaedics and as a carrier material for drug delivery. The examination deals 
with aspects such as; the chemical composition selected, inert filler particles used, early 
properties during preparation and handling (working, setting, injection time, translucency, 
radio-opacity), and final long-term properties such as dimensional stability and mechanical 
properties (fracture toughness, compressive and flexural strength, hardness and Young´s 
modulus). One specific topic deals with the sealing of the Ca-aluminate biomaterials to 
tissue - a key in the understanding of the mechanisms of nanostructural integration.  
2. Overview of properties of chemically bonded ceramics 
The Ca-aluminate bioceramics belong to the chemically bonded ceramics, which are usually 
presented or known as inorganic cements (Mangabhai, 1990). Three different cement 
systems – Calcium phosphates (CP), Calcium aluminates (CA) and Calcium silicates (CS) are 
discussed in some details in this section. Ceramic biomaterials are often based on 
phosphate-containing solubable glasses, and various calcium phosphate salts (Hench, 1998). 
These salts can be made to cure in vivo and are attractive as replacements for the natural 
calcium phosphates of mineralised tissues. The Ca-phosphate products are gaining ground 
in orthopaedics as resorbable bone substitutes. Biocements are often based on various 
calcium phosphate salts – sometimes in combination with Ca-sulphates (Nilsson, 2003). 
These salts can be made to cure in vivo and are attractive as replacements for the natural 
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mineralised tissues. However, these products have low compression strength values - in the 
interval 10-40 MPa - and are therefore questioned as load bearing implants.  
Materials based on Ca-aluminate (CA) and Ca-silicate  (CS)  with chemistry similar to that of 
Ca-phosphates (CP) contribute to some additional features of interest with regard to dental 
and orthopaedic applications (Scriviner, 1988). The inherent difference in water uptake 
between the CA/CS-systems and CP gives benefits as: 
 Higher mechanical strength. 
 Possibility to add fillers, e.g. for improved radio opacity. 
 Tuneable handling properties, e.g. rheology. 
Materials based on Ca-aluminate and Ca-silicate thus contribute to some additional features 
of interest with regard to dental and orthopaedic applications. These features are related to 
the high amount of water involved in the curing process, the early and high mechanical 
strength obtained, and the biocompatibility profile including in situ reactions with 
phosphates ions of the body fluid. Compressive strength of cements based on Ca-silicate 
and Ca-aluminate is in the range 50-250 MPa depending on the water to cement ratio. The 
mechanical properties tested for the three Ca-based cement systems are compiled in Table 1  
(Kraft, 2002, Loof et al 2003, Engqvist et al 2006). 
 
Property profile  after 7 days Ca-aluminate 
based material 
Ca-silicate based 
material 
Ca-phosphate 
based material 
Compressive strength (MPa) 100-200 100-150 < 100 
Flexural strength (MPa) 30-60 30-40 20-30 
Young´s modulus (GPa) Approx. 15 Approx. 11 Approx. 3 
Table 1. Mechanical property profile of the Ca-aluminate, Ca-silicate and Ca-phosphate 
systems 
The water content involved in the hydration of the different chemically bonded ceramics are 
presented in Table 2. 
 
System Typical phase(s) Oxide formula Mol % H2O Weight-% in 
hydrated product 
Ca-
phosphate 
Apatite 10CaO 3P2O5 H20 
 
   7 Approx 5 
Ca-aluminate Katoite + gibbsite 3CaO Al2O3 6 H20 
+ Al2O3 2H2O 
 > 60 
 
Approx  25 
Ca-silicate Tobermorite + 
amorphous phases
5CaO 6SiO2 5H2O  
+ Ca, Si)H2O 
> 30 Approx 20 
Table 2. The three chemically bonded ceramic systems most used for biomaterials 
2.1 Materials and basic function  
2.1.1 Main chemistry  
The injectability and handling features of the chemically bonded  ceramics  is mainly caused 
by the added water as the reacting phase with the powdered cements. This reaction is an 
acid-base reaction where water acts as a weak acid and the cement powder as a base. Several 
cement phases exist in the CaO - Al2O3 (CA) and in the CaO-SiO2 (CS) systems, see Figure 1, 
but only a few are suitable as injectable materials. For one of the most attractive phases –  
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Fig. 1. The phase diagram of the high-strength bioceramic cements  (Muan and Osbourne, 
1965) 
the mono Ca-aluminate, CaOxAl2O3 - the reaction at above 30 oC is described using cement 
chemical abbreviation as (Mangabhai, 1990); 
  3CA    +      12H           C3AH6  + 2AH3   (1) 
Or 
 3 (CaAl2O4) + 12 H2O  Ca3(Al(OH)4)2(OH)4 + 4 Al(OH)3  (2) 
This example demonstrates 1) the phases obtained, C3AH6 (katoite) and AH3 (gibbsite), and 
2) the amount water consumed in the reaction. The technological importance of this is that 
all the water needed for paste like consistency or injectability can be consumed in the 
formation of solid phases yielding products with low porosity, one of the requirements for 
high strength. As can be seen in Eq. (1) three CaAl2O4 units consume twelve water 
molecules during hardening. This can be compared with the hardening of Calcium 
Phosphate Cement (CPC) where practically no extra water is consumed. In the case of CPC, 
the reaction liquid is only used as a vehicle for the reaction to take place. In both cases the 
hardening and formation of a solid body are driven by the precipitation of small hydrates, 
nano-size crystals of katoite and gibbsite for CA, and apatite or brushite for CPC. The 
amount required water is as high as 28% for CA. The water content of apatite, Ca5(PO4)3OH, 
or 10CaOx3P2O5 H2O  (C10P3H) is  2%. The CPC-system may contain some additional Ca-
sulphate which can pick up some extra water. An additional 30 % Gypsum, CaSO4 ½ H2O to 
the CPC-system yields approximately a total water content of 6%. 
The rate of the hydration is controlled by 1) the cement phase, 2) the particle size of the 
cement, 3) the hydration temperature and 4) processing agents including especially 
accelerators. Typical powder composition data for CA-cements as biomaterials are shown in 
Slowly resorbable 
cements - CS 
Stable cements - CA 
Sintered inert ceramics 
- AS 
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Table 3. Zirconia or high-density glasses are added for achievement of increased strength 
and increased radio-opacity. The glasses are used preferentially in dental applications where 
translucency is an additional desired feature. The high radiopacity of zirconia or other 
heavy-element containing phases means that the physician during the injection can follow 
the paste penetration in bone tissue without risking any possible leakage of the material into 
the surrounding tissue.  
 
Compound  Formula Function Amount 
(wt-%)      
Mean particle 
size  
Ca-aluminate CaOxAl2O3 Cement binder  50-70  < 5 m 
Zirconium 
dioxide 
ZrO2 Radiopacier  20-40 < 1 m 
µ-Silica SiO2 Expansion and 
viscosity  controller 
< 10 <50 nm 
Table 3. Typical composition of an injectable biomaterial cement powder. 
Typical processing agents are accelerators/retarders, dispersants, viscosity agents to control 
reaction rate, temperature and the cohesiveness, and in general the rheology. Examples are 
lithium chloride, polycarboxylate polymers and cellulose, as well as glass poly-alkeonates. 
For the CS-system Ca-chloride at high concentrations is normally used as an accelerator. For 
cements as injectable biomaterials, the reaction rate must be controlled with respect to 
working time, setting time, curing time and the maximum temperature during hydration. 
Typical data are presented in Table 4. The cement reactions are all exothermic and the 
temperature raise is controlled by the specific cement phase selected, and the hydration rate 
and the amount of material injected. For dental application the temperature raise is limited 
to a few oC above 37 oC. For orthopaedic applications where larger amounts (2-10 cm3) are 
used the temperature raise is more pronounced but lower than that of the conventional 
PMMA-based materials (Lewis, 2006). 
 
System Working time at 23 
oC, min 
Setting time at 37 oC, 
min 
Max reaction temperature, 
oC 
Ca-aluminate Approx. 5 8-12 < 60,  
(for dental applications < 
40) 
Ca-silicate Approx. 10 15-18 < 45 
Ca-phosphate 5 10-12 < 40 
PMMA 5-10 11 < 90 
Table 4. Typical working and setting times and maximum reaction temperature of the 
systems discussed. 
The on-going precipitation of hydrates and the reduction of the amount of liquid phase 
result in the formation of a material skeleton. This repeating reaction is fast at the beginning, 
resulting in a hardened product within 4-20 minutes depending on intended application. 
Strength corresponding to load carrying capacity is reached after approximately one hour. 
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However, the final strength and in the case of dental applications the translucency (Engqvist 
et al 2004), are reached after approximately a few days maturing.  
It should be noted that for CBC materials, irrespective of chemistry (CA, CS or CPC), the 
final porosity cannot be zero. When the hydrates precipitate there is a contraction of 
approximately 10 %. The porosity is in the nanometer range and its exact amount is difficult 
to determine, but < 10 % of the filled space (the original liquid-phase volume) is estimated to 
be pores. However, this internal shrinkage related to hydration and precipitation yield no 
total shrinkage of the bulk material. In contrast, a limited expansion close to zero, may be 
induced (Kraft 2002). The porosity lowers the mechanical strength (although being in the 
nanometer range) but also enables liquids to diffuse into, or even through, the hardened 
CBC materials. This is an important feature when release of loaded drugs is a 
complementary aspect of the injectable biomaterial.  
3. Ca-aluminate – general description and property profile 
Ca-aluminates comprise double oxides of CaO and Al2O3. Several intermediate phases exist 
and these are - using the cement chemistry abbreviation system -  C3A, C12A7, CA, CA2 and 
CA6, where C=CaO and A=Al2O3. See Fig. 1 above. Table 5 presents typical property data. 
 
Property Typical value Interval* 
Compression strength, MPa 150 60-270 
Young´s modulus, GPa 15 10-20 
Thermal conductivity, W/mK 0.8 0.7-0.9 
Thermal expansion, ppm/K 9.5 9-10 
Flexural strength, MPa 50 20-80 
Fracture toughness, MPam1/2 0.5 0.3-0.8 
Corrosion resistance, water jet impinging, reduction in 
mm 
< 0.01 - 
Radio-opacity, mm 1.5 1.4-2.5 
Process temperature, oC > 30 30-70 
Working time, min 3 < 4 
Setting time, min  5 4-7 
Curing time, min 20 10-60 
Porosity after final hydration, % 15 5-60 
The interval is primarily related to the c/w ratio used, and the highest values are achieved with c/w 
ratio close to that of complete hydration with no excess of water 
Table 5. Mean property data of dental Ca-aluminate based materials (Kraft 2002, Lööf 2008, 
Lööf et al 2004,2005, Hermansson et al 2008) 
Due to reduced porosity based on the huge water uptake ability, the Ca-aluminate material 
exhibit the highest strength among the chemically bonded ceramics. The inherent  flexural 
strength is  above 100 MP based on measurement of the fracture toughness, which is about  
0.7 - 0.8 MPam1/2. The actual flexural strength is controlled by external defects introduced 
during handling and injection of the material. The thermal and electrical properties of Ca-
aluminate based materials are close to those of hard tissue, the reason being that Ca-
aluminate hydrates chemically belong to the same group as Ca-phosphates, the hard tissue 
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of bone. Another important property related to Ca-aluminate materials is the possibility to 
control the dimensional change during hardening. In contrast to the shrinkage behaviour of 
many polymer-based biomaterials, the Ca-aluminates exhibit a small expansion, 0.1-0.3 
linear-% (Kraft 2002).  
3.1 Biocompatibility including bioactivity  
Definitions used  
The terms biocompatibility and bioactivity are used in different ways by different categories 
of scientists. Below are presented the definitions used in this paper, mainly agreeing with 
the definitions discussed in (Williams, 1987) Biocompatibility: “The ability of a material to 
perform with an appropriate host response in a specific application”. 
Bioactivity (bioactive material): “A material which has been designed to induce specific 
biological activity”. Another definition according to (Cao and Hench,1996) “A bioactive 
material is one that elicits a specific response at the interface of the material which results in 
the formation of a bond between the tissues and the material”. 
Thus a material cannot in itself be classified as biocompatible without being related to the 
specific application, for which it is intended. Bioactivity from a materials viewpoint is 
frequently divided into in vitro and in vivo bioactivity. The in vitro bioactivity of a material is 
however only an indication that it might be bioactive in a specific in vivo application. 
Another aspect of bioactivity is that this term can be adequate only when the biomaterial is 
in contact with a cellular tissue. However, often a material is claimed to be bioactive if it also 
reacts with body liquids forming an apatite-phase. In vitro bioactivity is tested in phosphate 
buffer systems similar to that of saliva or body liquid, and apatite formation is the claimed 
sign of bioactivity. A further aspect of bioactivity and also biocompatibility deals with the 
different curing times and temperatures at which the observation (testing) is performed. 
This is important to issues such as initial pH-development, cohesiveness and initial strength. 
Finally the biocompatibility and bioactivity can only be confirmed in clinical situations, with 
the actual implant/biomaterial in the designed amount or content and shape. This is 
especially important for injectable biomaterials which are formed (hydrated) and cured in 
vivo, and for implants where movements, even micro-movement, can influence the outcome.  
Standards and methods 
Relating to the definition aspects above, the acceptance of a biomaterial is a crucial issue, 
and to some extent the question has been solved by relating to the following toxicological 
endpoints indicating biocompatibility as referred in the harmonized standard ISO 
10993:2003, which comprises the following sections: 
Cytotoxicity (ISO10993-5), Sensitization (ISO10993-10), Irritation/Intracutaneous reactivity 
(ISO10993-10), Systemic toxicity (ISO10993-11), Sub-acute, sub-chronic and chronic toxicity 
(ISO10993-11), Genotoxicity (ISO10993-3), Implantation (ISO10993-6), Carcinogenicity 
(ISO10993-3) and Hemocompatibility (ISO10993-4). 
This will be the main guideline when presenting the status of the biocompatibility of the 
CASPH-system, but was complemented by corrosion testing, elementary analysis, pH-
change and additional cytotoxicity testing. 
The corrosion resistance test – using a water jet impinging technique - was conducted 
according to EN  29917:1994/ISO  9917:1991,where removal of material is expressed as a 
height reduction using 0.1 M lactic acid as solution, pH 2.7 . The duration time of the test is 
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24 h. The test starts after 24 h hydration. The test probe accuracy was 0.01 mm. Values below 
0.05 mm per 24 h solution impinging are judged as acid resistant. 
Determination of Ca and Al in the solution during the hydration process of the Ca-
aluminate based material was performed using atomic absorption spectrometry (Liu et al 
2002). Standard solutions of different concentrations of Ca and Al were prepared according 
to the manual. Samples were prepared with a size of 10mm x 2mm height using a wet-press 
method, corresponding to a surface area of 224 mm2. The test pieces were placed in plastic 
bottles in inorganic saliva solution of pH 7. The amount of liquid was 10 ml in each bottle. 
The temperature selected was 37 oC. The inorganic saliva solution contained calcium 
chloride, magnesium chloride, sodium chloride, a phosphate buffer, hydro-carbonate and 
citric acid. The Ca-content in the saliva solution corresponded to 68 ppm. 1 ml solution was 
removed at 1, 7 and 28 days for analyses, and saliva was exchanged at 1, 7 and 28 days after 
every measurement. For the 28 days test additional samples were also taken 1 h after new 
solution was added. 
Measurement of  pH development during hydration of the material was conducted using a 
standard pH-meter. Samples were prepared according to the procedure for atomic 
absorption described above. The pH-testing was conducted in two separate ways. First the 
samples were immersed in saliva solution (pH =7) at 37 oC, and pH was measured 
continually over the whole experiment period (Test 1). 1 ml solution was removed at 1, 7, 14 
and 28 days for pH measurement. The second type of measurement comprised  immersion  
in 10 ml saliva solution at 37 oC,  where the  saliva was exchanged at 1, 7, 14 and 28 days. pH 
was measured at the time of observation and also after one hour in new saliva  (data within 
brackets), Test 2. 
Specimens at different setting stages were subjected to cytotoxicity testing by using primary 
cultures of human oral fibroblasts. A tissue culture insert retaining tested materials was 
assembled into a 12-well plate above the fibroblast monolayers. The cytotoxicity was 
determined by MTT reduction assay after various curing times. Specimens were set and 
hydrated at 37 oC for different periods of time, i.e. 0, 5, 30, 60 min, 24 h and 1 week and were 
then placed on tissue culture netwell for a cytotoxicity test. Both acute (1 and 24 h) and long 
term (1 week) in vitro toxicity tests were conducted with MTT assay.  
3.1.1 Biocompatibility including bioactivity of Ca-aluminate bioceramics 
Biocompatibility evaluation 
Summarized below are the results from several biocompatibility and bioactivity studies 
(Engqvist 2004, 2005, Faris 2006) where Ca-aluminate is used as a biomaterial in orthopaedic 
and dental applications. In vitro bioactivity studies show apatite formation on the surface of 
the Ca-aluminate materials exposed to phosphate buffer solution, an example shown in 
Figure 2 below. 
Corrosion resistance 
No height reduction at all was observed for two tested Ca-aluminate materials. Thus, 
according to the acid corrosion test, Ca-aluminate materials are judged as stable materials. 
The total absence of material loss, measured as height reduction in the acid corrosion test, is 
related to the general basic nature of the material, with possibility of neutralization of the 
acid in the contact zone – especially in the earlier stage of the hydration process. 
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Fig. 2. Cross section of the apatite-containing surface layer formed, SEM (Engqvist et al, 
2004) 
Ion release measured by atomic absorption spectrometry 
The results of Ca and Al determination in the solution during the hydration process of the 
Ca-aluminate based material are presented in Table 6. 
 
Ion tested  1h, ppm 24 hrs, ppm 7 days, ppm 28 days, ppm 
Ca 66 64 44 50     (70) 
Al 11.4 9.3 9.6 8.6    (1.2) 
Table 6. Ca and Al dissolution during hardening of the Ca-aluminate material, (The 1h 
testing at 28 days within brackets) 
The release of metal ions in water was below 5x10-2 ppm/(mm2 material) for aluminium and 
below 30x10-2 ppm/(mm2 material) for calcium, whereas somewhat higher aluminium 
content was measured in artificial saliva. The ion concentrations detected are generally not 
time-dependent during hydration. After the initial hydration time the ion concentration 
(molar) is determined by the solubility product of the phases formed (katoite = 5x10-26  and 
gibbsite = 3x10-24). Since the concentration of Ca in saliva is higher than what is obtained in 
the non-physiological aqueous solution (distilled water), it can be assumed that the filling 
material releases very limited amounts of Ca or Al once the material has hardened. The 
presence of Ca in saliva will decrease the solubility tendency of the calcium-aluminate-
hydrate phases.  
Based on a search in the literature, the FAO/WHO Joint Expert Committee on Food 
Additives  (JECFA) has provided a provisional figure for tolerable weekly aluminium intake 
of 7 mg/kg body weight. This corresponds to 1 mg/kg /day. The daily intake of aluminium 
via digestion/food is approximately 5 mg per day. For calcium the NIH Consensus 
Development Conference on Optimal Calcium Intake recommended an intake in the range 
800 mg/day for young children to 1000 – 1500 mg/day for adults depending on gender and 
age. For many people there is a need to supply additional calcium in order to stay healthy. 
The ion concentrations measured and the amounts of Ca and Al released are far below the 
concentrations of the elements produced from food intake and should therefore not pose 
any safety concerns at all. 
Apatite phase formed 
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Change in pH during hydration 
The results of the measurement of pH development during hydration of the Ca-aluminate 
based are shown in Table 7. The initial in vitro-pH is 10.5 in saliva. After 1 week, pH after 1 h 
dissolution time in saliva is approx. 8. 
 
Test No. At start 1h 24 hrs 7 days 14 days 28 days 
1 10.5 10.3 10.7 10.3 9.9 9.8 
2 10.5 10.2 10.2    (7.7) 9.9    (7.8) 9.5    (8.1) 9.2    (8.1) 
Table 7. Change of pH during initial hydration of  Ca-aluminate based materials 
The pH is high during the early stage of the hydration, but decreases with time and 
approaches neutrality. The reason for the high pH in the beginning is the general basic 
character of the material and the formation of OH- during the hydration process. In the 
clinical situation saliva is produced in a dynamic way, creating an environment capable of 
buffering surrounding solution to neutrality. In the clinical studies performed so far no 
adverse reactions have been reported from a possible elevated pH during the early part of 
the hydration. 
When Ca-aluminate material is combined with glass ionomer system the  pH-system 
becomes initially  acidic. However after 10 min the pH is above neutral, but will not exceed 
pH 9 (Jefferies et al 2009). 
Cytotoxicity testing 
The in vitro MTT reduction test of the experimental Ca-aluminate dental filling material in 
human oral fibroblast culture showed no obvious cytotoxicity. The average level of MTT 
reduction of the experimental dental filling material was close to 100% of the control values. 
The maximal variation (SD) was less than 30%. Different curing times of the test material 
did not seem to affect the cytotoxicity test results although one week curing produced the 
most stable testing results both in the short and long term tests. After a week the material 
can be considered as fully cured, i.e. stable. 
Morphological changes were not observed in any of the test groups at different MTT 
reduction testing points. As shown in Figure 3, the cell culture was typically fibroblastic 
with a slender and elongated form in both the control group and the group exposed to the 
examined material. In the exposed picture B even some precipitated hydrates are seen. 
 
 
Fig. 3. Morphological observation of human oral fibroblasts on an experimental Ca-
aluminate based material. A: Normal control. B: After exposure to the experimental filling 
material for one week (Liu et al 2002). 
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The standard for cellular biocompatibility in in vitro testing has been stated in the 
International Organization for Standardization (ISO) standards documents. The standard 
allows for the contact testing of solid dental materials for cytotoxicity with cell lines. Due to 
several disadvantages of direct contact testing, indirect testing methods have been 
developed and compared to the direct testing assays (Tang et al 2002). Introduction of a 
standard cell culture device, i.e. cell culture insert or transwell, provided an opportunity for 
such cytotoxicity screening of dental materials with indirect contact between material 
specimens and cell culture monolayer. It is believed that such a testing system more closely 
mimics the in vivo exposure pattern by providing the test of the material in both its solid and 
dissolved phases at the same time. It has been shown that this testing system has produced 
the most stable results as compared to other testing systems, such as direct contact test. In a 
complementary cytotoxicity test using the pulp derived cell response, the experimental CA-
material showed no sign of toxicity (Schmalz 2002).  
Harmonized standard ISO 10993:2003 
Further cytotoxicity and other biocompatibility aspects are summarised according to the 
outline in the harmonized standard ISO 10993:2003. An experimental orthopaedic Ca-
aluminate-based material was the test material. This material is judged as mildly cytotoxic 
during the initial curing, and as non-cytotoxic as cured material. See Table below. 
 
Type of test Method Cytotoxicity  (scale 0-4 or 100-0% 
During curing, undiluted ISO 10993-5, § 8.2 2 (mild) 
During curing, diluted  ISO 10993-5, § 8.2 0-1 (none-slight) 
During curing XTT-test 60 % (slight) 
During curing, diluted XTT-test > 70 % (none) 
Cured, undiluted ISO 10993-5, § 8.2 0 (none) 
Cured, diluted  diluted XTT-test > 70% (none) 
Table 8. Cytotoxicity testing of an orthopaedic Ca-aluminate based material 
A sensitization test (ISO 10993-10), Guinea Pig Maximization Test was performed with  the 
orthopaedic Ca-aluminate material during curing. No sensitizing potential was obtained. 
Additional irritation and delayed hypersensitivity testing according to ISO 10993-10:2002 
was conducted with both polar and non-polar extract from cured material, and the results 
showed no discrepancies after intracutaneous injections in the rabbit compared to the blank 
injections. The acute systemic toxicity study according to ISO 10993-11 was performed with 
both polar and non-polar extracts from cured Ca-aluminate material (Xeraspine), and the 
results showed no signs of acute systemic toxicity. Sub-acute, sub-chronic and/or chronic 
toxicity studies according to ISO 10993-11 were not conducted explicitly, since data from the 
two implantation studies in rabbit (see below) were judged to support that no long term 
toxicity is expressed. From the implantation studies histopathological organ and tissue data 
is available, and no adverse effects were reported.  
Additionally, in an in vivo genotoxicity assay, the mice micronucleus test of bone marrow 
was used. The extract (The experimental Ca-aluminate material during curing and cured 
material) was administered intraperitoneally twice. The results showed no clastogenic effect. 
Three in vivo implantation studies based on ISO 10993-6 have been performed. Two studies 
in rabbit (femur) and one in sheep (vertebrae). In vivo implantation studies are judged as the 
most relevant studies for documentation of safety of a product. In the rabbit implantation 
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studies Ca-aluminate material was compared to the PMMA-material CMW 1, and in the 
sheep study Ca-aluminate material was compared to the PMMA-material Vertebroplastic, 
and to the Bis-GMA material CortossTM. The results are summarized in Table 9. 
 
Implantation studies Species Reference material Result 
6-week femur Rabbit CMW-1 Minimal inflammation, 
very few inflammatory 
cells were present in bone, 
bone marrow and adipose 
tissues. 
6 (12) -month femur Rabbit CMW-1 No Al- accumulation 
 
12-week vertebrae Sheep Vertebroplastic 
Cortoss 
No inflammation, 
no Al-accumulation 
Table 9. Implantation studies in femur rabbit, and in vertebrae sheep, details in 
(Hermansson et al 2008) 
The 6 months femur study in rabbits included a 12 months subgroup. The amount of 
aluminium in blood and selected organs was analysed. The main target organs of the 
animals (kidney, lung, liver) were histopathologically investigated. Granulomatous 
inflammation in the cavity, pigmented macrophages and new bone formation were the 
treatment-related observations at 6- and12-months examination. No difference between Ca-
aluminate material and PMMA was detected. There were no signs of aluminium 
accumulation in the analysed tissues.  
In the 12-week study, the histopathology of vertebrae obtained one week after surgery 
showed the most severe inflammatory reaction to the surgery in the sham operated 
vertebrae. The bone marrow in the vertebrae filled with Ca-aluminate was not reported to 
be infiltrated by any inflammatory cells. In vertebrae obtained 12 weeks after surgery no 
inflammatory reactions were reported, and no obvious differences were observed in the 
pathological reactions to the surgery (sham) or the filler materials. Overview of the 
histological contact zone to the Ca-aluminate based material is shown in Figure 4.  
The analysis of serum samples showed low concentrations of aluminum in comparison to 
what is normal in humans. Since the concentration of aluminum did not increase after 
surgery and in some instances was lower after surgery than in the 0-samples, one may 
regard these concentrations as within the normal variation.  
 
 
Fig. 4. Histology image of an experimental Ca-aluminate material (black) in close contact 
with sheep vertebral bone. 
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Repeated haemocompatibility studies have been performed to evaluate possible reactions in 
whole human blood as a result of contact with Ca-aluminate materials (Axen et al 2004). 
Test items were an experimental Ca-aluminate based material and Xeraspine, 
Vertebroplastic and Norian (Calcium Phosphate Cement, Synthes Inc). A Chandler loop 
model was used in which circulating human blood was in contact with the test materials for 
up to 4 hours. For comparison, loops free from test materials were used. Platelet count 
(PLT), thrombin-antithrombin (TAT) complex, complement factors C3a and C5b-9 (TCC), 
and TNF-α were assayed. The degree of haemolysis was assessed by the Drabkin method. 
Norian (a calcium phosphate based material) invariably induced extensive clotting already 
after 60 minutes, verified macroscopically and also by significantly reduced PLT in 
comparison to the Control loops, whereas there was no significant reduction in PLT in the 
loops with Ca-alumiante material or Vertebroplastic, respectively, neither at 60 nor at 240 
minutes. The Ca-aluminate material did not induce haemolysis to a greater extent than any 
of the other materials tested. TCC was activated to a certain degree by the biomaterial, 
comparable to what is commonly observed for artificial materials. TNF-α generation, 
indicative of activation of white blood cells, was not enhanced by either Vertobroplastic or 
the  Ca-aluminate material.  
Based on all above mentioned data and generated toxicity data, it is considered that there is 
no reason to expect that the Ca-aluminate biomaterials when used in accordance with the 
intended clinical use will create any adverse effects. The Ca-aluminate based materials fulfill 
the requirements of the harmonized standard ISO 10993:2003.  
3.1.1.1 Complementary reactions of Ca-aluminate in presence of body liquid. 
Complementary reactions occur when the Ca-aluminate is in contact with tissue containing 
body liquid. Several mechanisms have been identified, which control how the Ca-aluminate 
material is integrated onto tissue. These mechanisms affect the integration differently 
depending on what type of tissue the biomaterial is in contact with, and in what state (un-
hydrated or hydrated) the CA is introduced. These mechanisms are summarized as follows 
and described in more details elsewhere (Hermansson, 2009); 
Mechanism 1:  Main reaction, the hydration step of CAC (Eq. 1 above)  
Mechanism 2: Apatite formation in presence of phosphate ions in the 
biomaterial 
Mechanism 3:  Apatite formation in the contact zone in presence of body liquid  
Mechanism 4: Transformation of hydrated Ca-aluminate into apatite and 
gibbsite  
Mechanism 5: Biological induced integration and ingrowth, i.e. bone formation 
at the contact zone 
Mechanism 6: Point-welding due to mass increase when in contact with body 
liquid. 
When phosphate ions or water soluble phosphate compounds are present in the biomaterial 
(powder or liquid) an apatite formation occurs according to the reaction 
5Ca2+  +  3PO43- + OH-    Ca5(PO4)3OH 
This complementary reaction to the main reaction occurs due to the presence of Ca-ions and 
a basic (OH-) environment created by the Ca-aluminate material. The solubility product of 
apatite is very small [Ks = 10-58], so apatite is easily precipitated. Body liquid contains 
among others the following ions HPO42- and H2PO4-. In contact with the Ca-aluminate 
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system and water during setting and hydration, the presence of  Ca-ions and hydroxyl ions, 
the hydrogen phosphate ions are neutralised according to 
HPO42-  +  H2 PO4- + OH-   PO42- + H2O, 
whereafter the apatite-formation reaction occurs 
5Ca2+  +  3PO43- + OH-    Ca5(PO4)3OH 
This reaction occurs upon the biomaterial surface/periphery towards tissue. The apatite is 
precipitated as nano-size crystals (Hermansson et al, 2006). See figure 5. 
 
 
Fig. 5. Nano-size apatite formation in the the contact zone to hard tissue 
Katoite is formed as a main phase, and is kept as katoite in the bulk material according to 
the mechanism 1 above. However, in long-time contact with body liquid containing 
phosphate ions the katoite is transformed at the interface tobody tissue into the at neutral 
pH even more stable apatite and gibbsite phases according to  
Ca3 
. (Al(OH)4)2 
. (OH)4  +  2 Ca
2+ + HPO4
2- + 2 H2PO4
-   
Ca5 
. (PO4)3 
. (OH) + 2 Al(OH)3 + 5 H2O 
When apatite is formed at the interface according to any of the reaction mechanisms 2-4 
above, at the periphery of the bulk biomaterial, the biological integration may start. Bone 
ingrowth towards the apatite allows the new bone structure to come in integrated contact 
with the biomaterial. This is an established fact for apatite interfaces. For the CA-system the 
ingrowth is discussed below, 4.4. The transition from tissue to the biomaterial is smooth and 
intricate. 
 
 
Fig. 6. Integration of CA in tissue – a model using albino adult New Zealand White rabbits 
(Hermansson et al, 2008). 
Apatite crystal 
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The actual contact zone developed depends on a combination of the above discussed 
mechanisms and the tissue. The latter varies from a cellular-free high content apatite tissue 
in the case of a dental enamel, via dentine to a bone structure with cellular and body liquid 
contact. Also the material can be in contact with other implant materials as dental crowns, 
dental screws or coatings on implants. In the tables 10 and 11 are summarized in which 
applications and specific tissues the demonstrated mechanisms are predominant. 
 
Tissue Mech 1 Mech 2 Mech 3 Mech 4 Mech 5 Mech 6 
Enamel x x     
Dentine x x X x (x)  
Bone x x X x x x 
Table 10. Type of tissue and possible mechanisms. 
 
Application Mech 1 Mech 2 Mech 3 Mech 4 Mech 5 Mech 6 
Cementation 
a. towards tissue  
b. towards implant 
 
x 
x 
 
x 
(x) 
 
X 
 
x 
 
x 
 
Dental fillings  
a. towards enamel  
b. towards dentine 
 
x 
x 
 
x 
x 
 
 
X 
 
 
x 
 
 
(x) 
 
Endo fillings 
a. orthograde  
b. retrograde incl bone 
 
x 
x 
 
x 
x 
 
 
X 
 
 
x 
 
 
x 
 
Coatings and augmentation
towards implant 
gap filling 
 
x 
x 
 
(x) 
x 
 
 
X 
 
 
x 
 
 
x 
 
 
x 
Table 11. Applications and possible mechanisms. 
Nanostructure and nano-porosity used in certain applications 
The nanostructure including nanoporosity developed in the Ca-aluminate biomaterial 
system when near complete hydration occurs, yields some unique properties related to how 
bacteriostatic and antibacterial properties may develop in the biomaterial. The nano-
porosity can also be used to control release of drugs incorporated the biomaterial. The 
background to this is that even if the total porosity is low, all porosity is open, thus allowing 
transport of molecules in the nanoporosity channels. The nanostructure used in thin film 
coatings will also be touched upon. 
Antibacterial aspects 
The surprising finding in studies recently performed (Doxa patent application 2010) shows 
that the bacteriostatic and antibacterial properties of the Ca-aluminate biomaterial are not 
primarily related to pH or specific ions and ion concentration or reducing agents, but to the  
hydration procedure and the microstructure  obtained. This also to some extent is an answer 
why highly biocompatible and even bioactive biomaterials can combine apparently 
contradictory features such as biocompatibility, bioactivity and apatite formation and 
environmental friendliness with bacteriostatic and antibacterial properties. 
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The bacteriostatic and antibacterial properties are primarily related to the development of 
the nanostructure and the nano-size porosity during hydration of the Ca-aluminate system. 
The initial low pH  ( < 8) of the system in the case of the presence of a polycarboxylic acid 
for cross-linking, is such not a hindrance for the antibacterial properties. The requirements 
of the microstructure of Ca-aluminate and/or Ca-silicate based biomaterials to achieve 
antibacterial properties are related to the general nanostructure obtained; A 
nanoparticle/crystal size of hydrates in the interval 15-40 nm, a nanoporosity size of  1-4 nm 
and the number of pores per square micrometer of at least 500, preferably > 1000.  
The above mentioned requirements will guarantee that the nanostructure will be free of 
large pores meaning no escape of bacteria within the original liquid, paste or dental void, 
during the hydration. The nanocrystals will participate on all walls, within the liquid, and 
on all inert particles and on bacteria within the original volume. The formation of 
nanocrystals will continue to all the void is filled. The bacteria will be totally encapsulated 
and will be chemically dissolved. Also the  number of nanopores will be extremely which 
will have the possibility of catching and fasten bacteria to the  hydrate surface – an analogue 
to how certain peptides may function as antibacterial material due to a structure with 
nanosize hole within the structure. 
4. Materials and biomaterials application  
Alternative dental materials and implant materials based on bioceramics are found within 
all the classical ceramic families: traditional ceramics, special ceramics, glasses, glass-
ceramics, coatings and chemically bonded ceramics (CBC) (Ravaglioli and Krajewski, 1992). 
The CBC-group, also known as inorganic cements, is based on materials in the system CaO-
Al2O3-P2O5-SiO2, where phosphates, aluminates, and silicates are found. Depending on in 
vivo chemical and biological stability, the CBC biomaterials can be divided into three 
groups: stable, slowly resorbable and resorbable. The choice for dental and stable materials 
is the Ca-aluminate based materials (Hermansson et al 2008). Slowly resorbable materials 
are found within Ca-silicates and Ca-phosphates, and fast resorbing materials among Ca-
sulphates and some Ca-phosphates. The stable biomaterials are suitable for dental 
applications, long-term load-bearing implants, and osteoporosis-related applications. For 
trauma and treatment of younger patients, the preferred biomaterial is the slowly resorbable 
materials, which can be replaced by new bone tissue (Nilsson, 2002). In this section are 
summarised some of the possible new applications using the strong chemically bonded 
ceramics based on Ca-aluminate. The presentation is devided in three application areas; 
dental, orthopaedics and drug delivery. 
The following product areas have been identified based on experimental material data, pre-
clinical studies, pilot studies and on-going clinical studies (Jefferies et al, 2009). The 
application areas are; Dental cement, endodontic products (orthograde and retrograde), 
sealants, restoratives, and pastes for augmentation and dental implant coatings. For low-
viscosity and early hardening of the CA, a complementary glass ionomer can preferrably be 
used. Clinical use of the materials is foreseen within the next coming years. The use of CA 
within odontology is based on the following features; early/rapid anchoring, high strength, 
long-term stability, no shrinkage, combined bonding and bulk material,  biocompatibility 
and in situ apatite formation ability (nanocrystals formed in the contact zone between 
material and tissue).  
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4.1 Dental applications 
The existing dental materials are mainly based on amalgam, resin composites or glass 
ionomers. Amalgam, originating from the Tang dynasty in China, was introduced in the 
early 19th century as the first commercial dental material. It is anchored in the tooth cavity 
by undercuts in the bottom of the cavity to provide mechanical retention of the metal. 
Although it has excellent mechanical characteristics it is falling out of favor in most dental 
markets because of health and environmental concerns. One exception is the US in which 
amalgam still has a redlatively large market share.  
The second generation material is the resin composites, first introduced in the late 1950s. 
These are attached to the tooth using powerful bonding agents that glue them to the tooth 
structure. After technical problems over several decades, these materials today have 
developed to a level where they work quite well and provide excellent aesthetic results. 
Despite the improvements, resin composites have some  drawbacks related to shrinkage, 
extra bonding, irritant components, a risk of post-operative sensitivity, and technique  
sensitivity in that they require dry field treatment in the inherently moist oral cavity. The 
key problem, due to shrinkage or possible degradation of the material and the bonding, is 
the margin between the filler material and tooth, which often fails over time leading to 
invasion of bacteria and secondary caries. Secondary caries is a leading cause of restorative 
failure and one of the biggest challenges in dentistry today. As a significant number of 
dental restorations today are replacement of old, failed tooth fillings, it is clear that tackling 
this problem is a major market need (Mjör, 2000). Secondary caries occurs not only after 
filling procedures but also following other restorative procedures such as the cementation of 
crowns and bridges. 
Glass ionomers were first introduced in 1972 and today are an established category for 
certain restorations and cementations. Their main weakness is the relatively low strength 
and low resistance to abrasion and wear. Various developments have tried to address this, 
and in the early 1990s resin-modified ionomers were introduced. They have significantly 
higher flexural and tensile strength and lower modulus of elasticity and are therefore more 
fracture-resistant. However, in addition to the problems of resin composites highlighted 
above, wear resistance and strength properties are still inferior to those of the resin 
composites. 
The nature of the mechanisms utilized by Ca-aluminate materials (especially Mechanism 1 
above) when integrating and adhering to tooth tissue and other materials makes these 
materials compatible with a range of other dental materials, including resin composite, 
metal, porcelain, zirconia, glass ionomers and gutta-percha. This expands the range of 
indications for Ca-aluminate based products from not only those involving tooth tissue, e.g. 
cavity restorations, but also to a range of other indications that involve both tooth tissue and 
other dental materials. Examples include dental cementation, base and liner and core build-
up and endodontic sealer /filler materials, which involve contact with materials such as 
porcelain, oxides and polymers and metals, and coatings on dental implants such as 
titanium or zirconia-based materials. 
The use of the Ca-alumiante materials may be a first step towards a paradigm shift for 
dental applications. The features are summarized below. 
Nanostructural integration  
- Reduced risk of secondary caries and restoration failure 
- Excellent biocompatibility   
www.intechopen.com
 Nanostructural Chemically Bonded Ca-Aluminate Based Bioceramics 
 
63 
- Reduced/no post-operative sensitivity, environmentally friendly and no allergy 
- Optimized consistency and setting properties for the intended application 
- Reliable clinical handling performance 
- Hydrophilic acid-base system with no extra bonding or no dry field precaution  
- Fast and easy clinical handling, no pre-treatment of tooth necessary 
- Excellent retentive and mechanical properties, no degradation of properties over time  
- Durable tooth-material restoration interface (longevity). 
Below are presented in more details the state–of-the-art for different possible applications of 
Ca-aluminate based materials.  
4.1.1 Dental cement 
Long-term success after cementation of indirect restorations depends on retention as well as 
maintenance of the integrity of the marginal seal. Sealing properties of great importance 
deal with microleakage resistance, the retention developed between the dental cement and 
the environment, compressive strength and acid resistance. Data presented below support 
the Ca-aluminate-system as highly relevant for dental cement materials. Integration with 
tooth tissue is a powerful feature and the foundation of the Ca-aluminate technology 
platform. Secondary caries occurs not only after filling procedures but also after other 
restorative procedures such as the cementation of crowns and bridges. The consequence of 
the difference in the mechanism of action between Ca-aluminate products and conventional 
products is illustrated by the study presented in details in (Pameijer et al , 2008, 2009), 
illustrated in Figure 2 below. It shows that the micro leakage, measured by dye penetration 
after thermo cycling, of a leading dental cement (Ketac Cem®, 3M) was significantly higher, 
both before and after thermo cycling compared to Ceramir C&B, a Ca-aluminate based 
product recently approved by FDA. This has also recently been verified using techniques for 
studying actual bacterial leakage. The above described nanostructural precipitation upon 
tissue walls, biomaterials and within the original Ca-aluminate paste is the main reason for 
this, in addition to a high acid corrosion resistance. 
General properties of the CAPH-system used as dental cement have been presented 
(Pameijer et al, 2008), see Fig. 7 and Table 12 below. General features of all the dental cement 
classes available are presented as a summary in Table 13 below. 
 
0
0,2
0,4
0,6
0,8
1
1,2
1,4
m
m
No Thermo cycling After thermo cycling
Mean Micro Leakage 
XeraCem™ Ketac Cem
 
Fig. 7. Micro leakage leakage of a Ca-aluminate based material (blue)  and Ketac Cem (red). 
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Material 
Net setting 
time, min 
Film thickness, 
m 
Compressive 
strength, MPa 
Crown 
retention, 
Kg/Force 
Ca-aluminate 
based 
4.8 15 196 (at 30days) 38.6 
Ketac Cem - 19 - 26.6 
RelyX-Unicem - - 157 39.4 
Table 12. Selected properties, Test methods according to SO 9917-1 
Material 
aspects 
Glass 
Ionomer
(GI) 
Resin-
modified GI
Resin 
(bonded) 
Self-adhesive 
Resin 
Zn- 
phosphate 
cement 
Ceramir 
C&B 
1. Type 
of material 
Polymer Monomer Monomer Monomer Inorganic 
material 
Ceramic- 
polymer 
2. Hardening 
mechanism 
Cross-
linking
Poly-
merisation
Poly- 
merisation 
Poly- 
merisation 
Acid-base 
reaction 
Acid-base  + 
cross-linking 
3. pH Acidic Acidic Acidic  
/neutral 
Acidic 
/neutral 
Acidic Acidic 
/basic 
4. Geo- 
metrical 
stability 
Non-
shrinking
Non-
shrinking 
Shrinks Shrinks Non- 
shrinking 
Non- 
shrinking 
5. Stability 
over time 
Degrades Degrades Degrades Degrades Degrades Stable 
6. Extra 
treatment 
- - Etching and 
bonding 
- - - 
7. Hydro- 
philic / 
phobic 
Hydro-
philic 
Hydrophilic Hydrophobic Initially 
hydrophilic, 
Hydrophobic
Hydrophilic Hydro-philic 
8. Integration 
mechanism 
Micro-
mechani-
cal 
retention, 
Chemical 
bonding
Micro-
mechanical 
retention / 
Chemical 
bonding / 
Adhesion
Adhesion / 
Micro-
mechanical 
retention 
Adhesion / 
Micro-
mechanical 
retention 
Micro-
mechanical 
retention 
Nano-
structural 
integration 
9. General 
behaviour 
Irritant Allergenic Allergenic Allergenic Non-
allergenic
Non-
allergenic 
10. Biocom-
patibility 
Good OK OK OK Good Good 
11. Bioactivty No No No No No Bioactive 
12. Sealing 
quality 
OK OK Good but 
operation 
sensitive
OK Acceptable Excellent 
 
Table 13. Overview of dental luting cements (Hermansson et al, 2010)   
Material aspects 4-12 in Table 13 are also relevant for all other Ca-aluminate based dental 
applications.  
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A clinical 2-year study comprising 35 cemented crowns was conducted at Kornberg School 
of Dentistry, Temple University, and follow-up data and feedback from participating 
dentists were excellent with no failures at all reported (Jefferies et al 2009).  
 
   
Fig. 8. Cemented ceramic crown (left), and HRTEM of the nanostructure of Ca-aluminate  
hydrates, hydrates formed in the interval 10-30 nm(right),  bar = 10 nm (Hermansson et al, 
2010) 
4.1.2 Endodontics 
In a review of the biocompatibility of dental materials used in contemporary endodontic 
therapy (Haumann and Love, 2003) amalgam was compared with gutta-percha, zinc oxide-
eugenol (ZOE), polymers, glass ionomer cements (GICs), composite resins and mineral 
trioxide aggregate (MTA). A review (Niederman, 2003) of clinical trials of in vivo retrograde 
obturation materials summarized the findings. GIC’s appeared to have the same clinical 
success as amalgam, and orthograde filling with gutta-percha and sealer was more effective 
than amalgam retrograde filling. Retrograde fillings with composite and Gluma, EBA 
cement or gold leaf were more effective than amalgam retrograde fillings. However, none of 
the clinical trials reviewed in included MTA. In a 12 week microleakage study,  the MTA 
performance was questioned compared to that of both amalgam and a composite (Alamo et 
al, 1999).  
The Ca-aluminate-based material discussed in this paper belongs to the same material 
group as MTA, the chemically bonded ceramics. MTA is a calcium silicate (CS) based 
cement having bismuth oxide as filler material for improved radio-opacity, whereas the Ca-
aluminate material consists of Ca-aluminate phases CA and CA2 with zirconia as filler 
material. MTA is claimed to prevent microleakage, to be biocompatible, to regenerate 
original tissues when placed in contact with the dental pulp or periradicular tissues, and to 
be antibacterial. The product profile of MTA describes the material as a water-based 
product, which makes moisture contamination a non-issue (Dentsply 2003). The CA-cement 
materials are more acid resistant than the CS-based materials, and in general show higher 
mechanical strength than the CS materials. A two-year and a five-year retrospective clinical 
study of Ca-aluminate based material have been conducted (Pameijer et al, 2004, Kraft et al, 
2009). The study involved patients with diagnosis of either chronic per apical osteitis, 
chronic per apical destruction, or trauma. Surgery microscope was used in all cases. For 
orthograde therapy the material was mixed with solvent into appropriate consistency and 
put into a syringe, injected and condensed with coarse gutta-percha points. Machine burs 
were employed for root canal resection. For the retrograde root fillings, the conventional 
surgery procedure was performed. The apex was detected with surgery microscope and 
rinsed and prepared with an ultrasonic device. Crushed water-filled CA-tablets were then 
inserted and condensed with dental instruments. The patients’ teeth were examined with X-
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ray, and three questions regarding subjective symptoms were put to patients: 1. Have you 
had any persistent symptoms?  2. Do you know which tooth was treated?  3. Can you feel 
any symptoms at the tooth apex?  
In 13 of the 17 treated patients the diagnosis was chronic perapical osteitis (c p o). These 
were treated with retrograde root filling (rf) therapy. Three patients suffered from trauma or 
chronic perapical destruction, and these patients were treated with orthograde therapy. Out 
of 17 patients (22 teeth) treated, 16 patients (21 teeth) were examined with follow-up x-ray 
after treatment and also after two years or more. The additional patient was asked about 
symptoms. The results of both the clinical examination and the subjective symptoms were 
graded into different groups related to the success of the therapy. The results of the 2-year 
and the 5-year study are shown in Table 14.  
 
 1  Complete 
healing
2 Incomplete 
healing
3 Uncertain 4 Failure 
 2-year        5-year 2-year         5-year 2 year  5-year 2-year  5-year 
Nos. of teeth 18                 14 3                    2 0                0 1                 0 
Percentage 82                   87 14                  13 0                0 4                 0 
Table 14. Summary of the results (Score 1 and 2 considered successful, score 3 and 4 failure) 
Figures 9-10 show examples of the X-ray examination of orthograde and retrograde 
treatments. 
 
   
Fig. 9. Tooth 21 (patient14) a) condensing with a Gutta-percha pointer, b) just after treatment  
and c) at two year control 
 
   
Fig. 10. Tooth 21 (patient 9) at treatment (left) and at two year control (middle) and at 5 year 
control (right) 
In summary 21 out of 22 treated teeth have acceptable results being either symptom free or 
judged healed after clinical examination. The single failure can probably not be attributed to 
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the material, but rather to the difficulty of treating and sealing a multi-channelled tooth. The 
use of CA’s as root canal sealers is indirectly supported in “Introduction to Dental 
Materials” by van Noort (van Noort, 1994), where the following materials characteristics are 
looked for; biocompatible, dimensionally stable, antibacterial and bioactive. The results in 
this study can be interpreted as a success in meeting these materials requirements. 
Already in the 1970s, Calcium aluminate (CA) was suggested as a biomaterial and tested in 
vivo. Hentrich et al (Hentricht et al, 1994) compared CA with alumina and zirconia in an 
evaluation of how the different ceramics influenced the rate of new bone formation in 
femurs of rhesus monkeys. Hamner et al (Hamnar and Gruelich, 1972) presented a study in 
which 22 CA roots were implanted into fresh natural tooth extraction sites in 10 baboons for 
periods ranging from 2 weeks to 10 months. In both studies CA successfully met the criteria 
for tissue adherence and host acceptance. 
4.1.3 Dental filling materials 
An important feature of the hydration mechanisms of the Ca-aluminate based materials is 
the nanostructural integration with and the high shear strength developed towards dental 
tissue. This makes both undercut (retention) technique and bonding techniques redundant. 
The Ca-aluminate approach to dental filling technique is new. With this technique, the 
chemical reactions cause integration when the bioceramic material is placed in the oral 
cavity at body temperature and in a moist treatment field. Figure 11 shows a TEM 
(transmission electron microscopy) illustration of the interface between the CA-based 
material and dentine. This establishes a durable seal between bioceramic and tooth. 
Whereas amalgam attaches to the tooth by mechanical retention and resin-based materials 
attach by adhesion, using bonding agents, etchants, light-curing or other complementary 
techniques, the CA-materials integrate with the tooth without any of these, delivering a 
quicker, simpler and more robust solution. 
 
 
Fig. 11. Nanostructural integration of CAPH-material with dentine (gray particles in the 
biomaterial are glass particles) 
The general aspects of Ca-aluminate based materials have been presented in two Ph D 
Thesis-publications. Important aspects of Ca-aluminate materials as dental filling materials 
are dealt with, such as dimensional stability, acid corrosion and wear resistance, and 
biocompatibility and mechanical properties (Kraft 2002, Lööf et al 2003). 
4.1.4 Coatings on dental implant and augmentation 
For successful implantation of implants in bone tissue, early stabilisation is of great 
importance (Ellingsen and Lyngstaadas, 2003). This includes both orthopaedic and dental 
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implants. Even small gaps may lead to relative micro-motions between implant and the 
tissue, which increases the risk of implant loosening over time due to formation of zones of 
fibrous tissues at the implant-tissue interface. Early loading of implants is of particular 
interest for dental implants (Vercaigne et al, 1998). The use of surface coatings technology is 
today an established method to reduce the problem with poor interfacial stability for 
implants. With coatings technology, structural characteristics of the implant (e.g. strength, 
ductility, low weight or machinability) may be combined with surface properties promoting 
tissue integration. There are several established coating deposition techniques, e.g. physical 
vapour deposition (sputtering) and thermal spraying techniques. Coatings based on calcium 
phosphates are the most used ones.  
This section deals with coatings deposited with established methods, with the aim of 
improving particularly the early stage anchoring of metal implants to bone tissue by 
exploring in vivo hydration of coatings or pastes based on chemically curing ceramics. The 
study focuses on calcium aluminate in the form of coatings and paste. Results are presented 
from an implantation study with flame-sprayed coating on titanium implants and uncoated 
implants augmented with a calcium aluminate paste in the hind legs of rabbits. Implants 
were applied with the paste composed of a mixture of CaO·Al2O3 and CaO·2Al2O3. The 
paste was applied manually as a thin layer on the threaded part of the implant just before 
implantation. The uncoated and coated implants were sterilised with hot dry air at 180 ºC 
for 2 hrs. Female albino adult New Zealand White rabbits with a body weight around 2.5 kg 
were used. Each animal received four implants, two in each hind leg. Implants were placed 
in the distal femoral metaphysis as well as in the proximal tibial metaphysis. Surgery 
followed standard procedure. The implants were screwed into predrilled and threaded 
cavities. Necropsy took place after 24 hrs, 2 and 6 weeks (Axen et al, 2005).  
No negative effects of the implants on the general welfare of the animals were observed. The 
healing progressed in a normal and favourable way. As for the removal torque recordings, 
all calcium aluminate coatings types provided an improved implant anchoring to bone 
tissue after in vivo hydration, as compared to that of the pure metal implants. Implants on 
the tibia and femur side of the knee gave similar removal torques. Table 15 provides average 
values from both tibia and femur sides. 
 
Implant type 24 hrs (n) 2 weeks (n) 6 weeks (n) 
Flame spraying 7.0 (8) 7.0 (8) 25 (6) 
Paste augmentation 6.6 (8) 15 (6) 13 (4) 
Rf-PVD 12 (4) - - 10 (4) 
Uncoated reference 3.8 (8) 5.7 (6) 14 (4) 
Table 15. Removal torque (Ncm) for dental implants in rabbit hind legs (tibia and femur). 
24 hrs after implantation, calcium aluminate in-between the implant and tissue increased the 
removal torque to about double that of the uncoated reference implants, independently of 
means of application (coatings or paste). This is considered to be attributable to the point-
welding according to integration mechanism 6 above. Two weeks after implantation, 
implants combined with paste augmentation provide the highest removal torque; flame 
sprayed coatings also improve the torque relative to the uncoated system. Six weeks after 
implantation, all systems are relatively similar (considering the uncertainty due to scatter 
and statistics), apart from the sprayed system which shows significantly higher values. 
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Fig. 12. High-resolution TEM  of Ti – CA-paste interface, nano-mechanical integration, bar = 
10 nm. 
4.2 Orthopaedic applications 
Within orthopedics the following areas for Ca-aluminate based materials have been 
identified; percutaneous vertebroplasty (PVP) and kyphoplasty (KVP), trauma and general 
augmentation.  
The benefits of the injectable ceramic biomaterials based on CA related to orthopaedic 
applications are  
During the surgical procedure (Engqvist et al, 2005, Lööf et al 2008) 
 High radiopacity allows for superior visibility of the cement during and increases the 
probability to detect potential leakages during injection  (See Figs. 13-14 below) 
 
 
Fig. 13. Percutaneous vertebroplasty using a CA-material. 
 
 
Fig. 14. Vertebral compression factures, restored by CA-material. 
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 High and linearly increasing viscosity reduces the risk of leakage and gives a  
 predictable handling. 
 High cohesiveness optimizes the cement’s filling pattern in the vertebra. 
 No toxic or smelling fumes 
And after the procedure (Jarmar et al, 2008, Engqvist et al 2006) 
 Mechanical strength  
 Biocompatibility including integration  
 Long-term stability i.e. non-resorbable systems. 
4.3 Drug carrier for drug delivery 
General aspects of ceramics for use in drug delivery of drugs are presented by Ravaglioli et 
al and by Lasserre and Bajpaj (Ravaglioli et al, 2000, Lasserre and Bajpaj, 1998). A short 
description of carrier materials for drug delivery using chemically bonded ceramics, 
especially Ca-aluminate and/or Ca-silicate systems are given below. The CBC carrier 
material based on CA and CS structures exhibit some attractive features. The  
manufacturing procedure at  low temperatures, where no or limited  degradation of the 
medicaments occur, and the  microstructure developed with open porosity as nano-sized 
channels as described  above, are the basic features that open up a possibility for  controlled 
release of medical agents. The precursor powder cures as a result of hydration reactions, 
between a ceramic oxide powder, primarily Ca-silicates and/or Ca-aluminates, and water. 
Through the hydration, new phases of hydrates are formed, which to a great part establish 
the microstructures needed to control the release of drugs incorporated in the injectable 
precursor material. An injectable material is formed into a paste by mixing it with a water-
based hydration liquid, which is then ready to be injected. Directly after the injection, the 
paste starts to develop the final microstructure. The water-based liquid may also comprise 
viscosity-controlling additives. These may be loaded with the drug before preparation of the 
final injectable paste. A couple of unique reaction conditions related to the production of 
materials yields materials with a variety of possible microstructures with porosities from the 
nanoscale to the microscale. variety of possible microstructures with porosities from the 
nanoscale to the microscale. 3) pore size and pore channel size, and 4) combination of 
different porosity structures (Hermansson, 2010). Porosity generated during the hydration 
of the Ca-aluminates and Ca-silicates is open porosity due to the reaction mechanism, and 
can be in the interval of 5-60 vol.-%. The average pore channel size (i.e. the diameter of the 
pores formed between the particles of the hydrated material) may be 1-10 nm. The crystal 
size of the reacted hydrates is in the interval 10-50 nm. This was established by BET-
measurements, where the specific surface area of dried hydrated CA was determined to be 
in the interval 400-500 m2, corresponding to a particle size of approximately 25 nm, and by 
HRTEM [7], Fig. 1 below. When short hydration time and/or low amount of water, or 
moisture at relative humidity > 70 %, are used, additional porosity is achieved with pore 
sizes in the interval 0.1-1 micrometer due to incomplete reaction. The different pore sizes 
obtained can be utilized for controlled release of drugs, when the Ca-aluminate implant 
material also works as a carrier of medicaments. 
Drug loading and controlled release of drugs  
The following properties are of significance with regard to the carrier for controlling the 
drug release; Type of ceramic precursor for producing the chemically bonded ceramic, grain 
size distribution of the precursor powder particles and general microstructure of the 
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material, he microstructure of the additional particles for drug incorporation, and additives 
to ensure complementary porosity.  
The loading of the drug can be performed in several ways. The drug may be included, either 
partially or fully, in the powder or in the hydration liquid. Time and temperature for 
hydration are selected with regard to the drug and drug loading and to the selected release 
criteria. The manufacturing of the carrier can be done completely before or during loading 
of the drug. This renders a controlled release time to be selected from a few hours to days 
and months.  
The drug is introduced in the carrier by mixing the drug into the precursor powder, or the 
hydrated CBCs or other porous phases. The material can be formed into a paste by mixing it 
with a water-based hydration liquid. The powder can also be pressed into pellets, which 
thereafter are soaked in the liquid. The paste or the soaked pellets start to develop the 
microstructure that to a great extent will contribute to the controlled release of the drug. The 
time and temperature after the mixing will determine the degree of hydration, i.e. the 
porosity obtained. The porosity can be controlled within a broad interval of open porosity.  
5. Conclusion  
The Ca-aluminate technology provides a platform upon which Ca-aluminate based 
materials may work as a general biomaterial and as a complement to other chemically 
bonded ceramics based on phosphates, silicates or sulphates. Identified areas are in the first 
place within the dental and orthopedic areas, where injectable stable biomaterials are 
required. These include also properties as bioactivity related to apatite formation, 
antibacterial properties as well as nanostructural features useful for carriers for controlled 
drug delivery. The studies presented in this paper can be summarised as follows; 
 Nano-structural integration and apatite formation provide important benefits to both 
the dentist and patient, notably minimal micro-leakage, perfect seal at the interface 
between tooth and material and as a result longer-lasting treatment results. 
 The potential use of the Ca-aluminate materials for implant applications is based on the 
following features: nanostructural integration with tissue, possible apatite formation, 
and a mass increase yielding early point welding between the biomaterial and 
surrounding.  
 The following product areas have been identified based on experimental material data, 
pre-clinical studies, pilot studies and on-going clinical studies: dental cement, 
endodontic products (orthograde and retrograde), sealants, restoratives, underfillings, 
and pastes for augmentation and dental implant coatings.  
 Consequences of nanostructural contact integration of the Ca-aluminate system are 
reduced risk of secondary caries and restoration failure, and reduced post-operative 
sensitivity.  
 The Ca-aluminate material can be used as a vehicle for transport and delivery of the 
medicament and as an injectable implant. The combination of the material as carrier 
and implant material makes site-specific placement of drugs and implants possible. By 
introducing optional additives, or by changing the w/c ratio, the release time can be 
controlled from short time periods (a few hours) to prolonged time periods (day and 
weeks). The release time is also dependant upon where the drug is placed. In cortical 
bone a release time of months seems possible.  
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 The Ca-aluminate materials are not degradable and do not induce clotting or 
haemolysis.  
 The first product in a series - a dental luting cement- was recently launched on the 
European and the US markets. 
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